In Vitro Culture, Drug Sensitivity, and Transcriptome of Plasmodium Vivax Hypnozoites

Anders, 2010, Differential expression analysis for sequence count data, Genome Biol., 11, R106, 10.1186/gb-2010-11-10-r106 Auburn, 2016, A new Plasmodium vivax reference sequence with improved assembly of the subtelomeres reveals an abundance of pir genes, Wellcome Open Res., 1, 4, 10.12688/wellcomeopenres.9876.1 Balaji, 2005, Discovery of the principal specific transcription factors of Apicomplexa and their implication for the evolution of the AP2-integrase DNA binding domains, Nucleic Acids Res., 33, 3994, 10.1093/nar/gki709 Baragaña, 2015, A novel multiple-stage antimalarial agent that inhibits protein synthesis, Nature, 522, 315, 10.1038/nature14451 Battle, 2014, Geographical variation in Plasmodium vivax relapse, Malar. J., 13, 144, 10.1186/1475-2875-13-144 Benjamini, 1995, Controlling the false discovery rate: a practical and powerful approach to multiple testing, J. R. Stat. Soc. Ser. B, 57, 289 Bennett, 2013, Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria, N. Engl. J. Med., 369, 1381, 10.1056/NEJMc1301936 Berger, 2015, Enhancing the functional maturity of induced pluripotent stem cell-derived human hepatocytes by controlled presentation of cell-cell interactions in vitro, Hepatology, 61, 1370, 10.1002/hep.27621 Campo, 2015, Killing the hypnozoite - drug discovery approaches to prevent relapse in Plasmodium vivax, Pathog. Glob. Health, 109, 107, 10.1179/2047773215Y.0000000013 Carpenter, 2006, CellProfiler: image analysis software for identifying and quantifying cell phenotypes, Genome Biol., 7, R100, 10.1186/gb-2006-7-10-r100 Chattopadhyay, 2010, Establishment of an in vitro assay for assessing the effects of drugs on the liver stages of Plasmodium vivax malaria, PLoS One, 5, e14275, 10.1371/journal.pone.0014275 Collins, 1996, Primaquine resistance in Plasmodium vivax, Am. J. Trop. Med. Hyg., 55, 243, 10.4269/ajtmh.1996.55.243 Combe, 2009, Clonal conditional mutagenesis in malaria parasites, Cell Host Microbe, 5, 386, 10.1016/j.chom.2009.03.008 Cubi, 2017, Laser capture microdissection enables transcriptomic analysis of dividing and quiescent liver stages of Plasmodium relapsing species, Cell. Microbiol., 19, e12735, 10.1111/cmi.12735 Dembele, 2011, Towards an in vitro model of Plasmodium hypnozoites suitable for drug discovery, PLoS One, 6, e18162, 10.1371/journal.pone.0018162 Dobin, 2013, STAR: ultrafast universal RNA-seq aligner, Bioinformatics, 29, 15, 10.1093/bioinformatics/bts635 Ghidelli-Disse, 2014, Identification of Plasmodium PI4 kinase as target of MMV390048 by chemoproteomics, Malar. J., 13, P38, 10.1186/1475-2875-13-S1-P38 Goller, 2007, Regional differences in the response of Plasmodium vivax malaria to primaquine as anti-relapse therapy, Am. J. Trop. Med. Hyg., 76, 203, 10.4269/ajtmh.2007.76.203 Gural, 2018, Engineered Livers for Infectious Diseases, Cell. Mol. Gastroenterol. Hepatol., 5, 131, 10.1016/j.jcmgh.2017.11.005 Hollingdale, 1985, In vitro culture of two populations (dividing and nondividing) of exoerythrocytic parasites of Plasmodium vivax, Am. J. Trop. Med. Hyg., 34, 216, 10.4269/ajtmh.1985.34.216 Iwanaga, 2012, Identification of an AP2-family protein that is critical for malaria liver stage development, PLoS One, 7, e47557, 10.1371/journal.pone.0047557 Jones, 2008, CellProfiler Analyst: data exploration and analysis software for complex image-based screens, BMC Bioinformatics, 9, 482, 10.1186/1471-2105-9-482 Kafsack, 2014, A transcriptional switch underlies commitment to sexual development in malaria parasites, Nature, 507, 248, 10.1038/nature12920 Kaplowitz, 2005, Idiosyncratic drug hepatotoxicity, Nat. Rev. Drug Discov., 4, 489, 10.1038/nrd1750 Khetani, 2008, Microscale culture of human liver cells for drug development, Nat. Biotechnol., 26, 120, 10.1038/nbt1361 Krotoski, 1980, Relapses in primate malaria: discovery of two populations of exoerythrocytic stages. Preliminary note, Br. Med. J., 280, 153, 10.1136/bmj.280.6208.153-a Krotoski, 1982, Demonstration of hypnozoites in sporozoite-transmitted Plasmodium vivax infection, Am. J. Trop. Med. Hyg., 31, 1291, 10.4269/ajtmh.1982.31.1291 Kuhen, 2014, KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission, Antimicrob. Agents Chemother., 58, 5060, 10.1128/AAC.02727-13 Li, 2011, RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome, BMC Bioinformatics, 12, 323, 10.1186/1471-2105-12-323 López-Barragán, 2011, Directional gene expression and antisense transcripts in sexual and asexual stages of Plasmodium falciparum, BMC Genomics, 12, 587, 10.1186/1471-2164-12-587 Love, 2014, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2, Genome Biol., 15, 550, 10.1186/s13059-014-0550-8 March, 2015, Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens, Nat. Protoc., 10, 2027, 10.1038/nprot.2015.128 Mazier, 1984, Cultivation of the liver forms of Plasmodium vivax in human hepatocytes, Nature, 307, 367, 10.1038/307367a0 McNamara, 2013, Targeting Plasmodium PI(4)K to eliminate malaria, Nature, 504, 248, 10.1038/nature12782 Melnikov, 2011, Hybrid selection for sequencing pathogen genomes from clinical samples, Genome Biol., 12, R73, 10.1186/gb-2011-12-8-r73 Mikolajczak, 2015, Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice, Cell Host Microbe, 17, 526, 10.1016/j.chom.2015.02.011 Miller, 2012, Plasmodium yoelii macrophage migration inhibitory factor is necessary for efficient liver-stage development, Infect. Immun., 80, 1399, 10.1128/IAI.05861-11 Modrzynska, 2017, A knockout screen of ApiAP2 genes reveals networks of interacting transcriptional regulators controlling the plasmodium life cycle, Cell Host Microbe, 21, 11, 10.1016/j.chom.2016.12.003 Ng, 2015, Human iPSC-derived hepatocyte-like cells support plasmodium liver-stage infection in vitro, Stem Cell Reports, 4, 348, 10.1016/j.stemcr.2015.01.002 Noe, 2000, Spatial and temporal dynamics of the secretory pathway during differentiation of the Plasmodium yoelii schizont, Mol. Biochem. Parasitol., 108, 169, 10.1016/S0166-6851(00)00198-5 Ploss, 2010, Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures, Proc. Natl. Acad. Sci. USA, 107, 3141, 10.1073/pnas.0915130107 Price, 2014, Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis, Lancet Infect. Dis., 14, 982, 10.1016/S1473-3099(14)70855-2 Rosenberg, 1989, Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax, Science, 245, 973, 10.1126/science.2672336 Sattabongkot, 2006, Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax, Am. J. Trop. Med. Hyg., 74, 708, 10.4269/ajtmh.2006.74.708 Shanks, 2013, The activation of vivax malaria hypnozoites by infectious diseases, Lancet Infect. Dis., 13, 900, 10.1016/S1473-3099(13)70095-1 Shortt, 1948, Pre-erythrocytic stage in mammalian malaria parasites, Nature, 161, 126, 10.1038/161126a0 Sinha, 2014, A cascade of DNA-binding proteins for sexual commitment and development in Plasmodium, Nature, 507, 253, 10.1038/nature12970 Sturm, 2006, Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids, Science, 313, 1287, 10.1126/science.1129720 Wells, 2010, Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination, Trends Parasitol., 26, 145, 10.1016/j.pt.2009.12.005 White, 2011, Determinants of relapse periodicity in Plasmodium vivax malaria, Malar. J., 10, 297, 10.1186/1475-2875-10-297 WHO, 2015 Younis, 2012, 3,5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potential, J. Med. Chem., 55, 3479, 10.1021/jm3001373 Yuda, 2009, Identification of a transcription factor in the mosquito-invasive stage of malaria parasites, Mol. Microbiol., 71, 1402, 10.1111/j.1365-2958.2009.06609.x Yuda, 2010, Transcription factor AP2-Sp and its target genes in malarial sporozoites, Mol. Microbiol., 75, 854, 10.1111/j.1365-2958.2009.07005.x Zeeman, 2016, PI4K is a prophylactic, but not radical curative target in Plasmodium vivax-type malaria parasites, Antimicrob. Agents Chemother., 60, 10.1128/AAC.03080-15